University of Illinois at Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Illinois at Chicago sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
University of Illinois at Chicago: 430 sponsored US clinical trials, 115 recruiting.
University of Illinois at Chicago sponsors 430 registered US clinical trials on ClinicalTrials.gov, 115 of them currently recruiting, and 236 completed. 30 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
University of Illinois at Chicago ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 271 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 1 of 9
Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT07647250
Tele-CE in Severe Stroke
NCT07652970
Resilience-Building for Advance Care Planning
NCT07428278
FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
NCT07332741
Effects of Delay in Hearing Assistive Technology
NCT07533071
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
NCT07175051
LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)
NCT07408531
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
NCT07458425
Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
NCT07296952
Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.
NCT07387445
Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
NCT07076849
Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression
NCT06591091
STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study
NCT07269080
Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease
NCT07402811
CBTi for the Treatment of Insomnia in Type 1 Diabetes
NCT07091318
Home Based Functional Balance Intervention for Multiple Sclerosis
NCT07355387
Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions
NCT06823453
Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery
NCT07111182
Oral Health Intervention for Caregivers of Children Presenting for Dental Surgery
NCT07220850
Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function
NCT07006818
Ischemic Preconditioning in Osteoarthritis and Back Pain
NCT07003113
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
NCT07014111
Aging and Task-specific Training to Reduce Falls
NCT07094659
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
NCT06919081
Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement
NCT05736666
Testing the Effectiveness and Implementation of a Meditation App for Youth in the Legal System
NCT06997120
Enhancing Diabetes Care: Exposome &Amp; Sensors
NCT06989008
Circadian Mechanisms, Glucose, and CV Risks in T1D
NCT06624046
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
NCT06754280
Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis
NCT05427695
EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
NCT07085351
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
NCT06802315
Embracing Morning BReakfast and Activity for Classroom Engagement
NCT06555627
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
NCT04827420
Functional Balance Intervention in Multiple Sclerosis
NCT06341023
Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older
NCT06636058
Effect of Continuing Versus Holding Metformin During Hospitalizations.
NCT06296836
LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
NCT06576635
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
NCT06441890
Feasibility Testing a Meditation App for Professionals Working With Youth in the Legal System
NCT06555172
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
NCT06266416
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
NCT06205225
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
NCT06550804
TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure
NCT06473532
Time-restricted Eating Among Pregnant Females With Severe Obesity
NCT06477120
Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation
NCT05736198
GU-01: Glycyrrhizin in Prostate Cancer
NCT06378346
UIC Multi-Ethnic DCM Registry
NCT07145138
Transcranial Direct Current Stimulation in Conjunction with Individualized Physical Therapy for Individuals with Chronic Knee Pain
NCT06132412
HCV Tappt Adherence Study
NCT06263829
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 43 |
| Phase 3 | 11 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Illinois at Chicago pipeline
115 recruiting of 430 indexed (27% open); 236 completed (55%).
Phase mix: 30 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Illinois at Chicago: open-pipeline peers nationwide
Peers matched on 430 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
University of Illinois at Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this University of Illinois at Chicago page
430 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Chicago or any single study.
- 115 of University of Illinois at Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition University of Illinois at Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Illinois at Chicago pipeline card: 430 registered trials from official public datasets.Report a data error.